Gladstone Commercial Corporation To Be Added To the MSCI U.S. REIT Index (RMZ)
Dec 01, 2016 21:15 pm UTC| Business
MCLEAN, Va., Dec. 01, 2016 -- Gladstone Commercial Corporation(NASDAQ:GOOD) ("Gladstone Commercial"), a real estate investment trust focused on acquiring, owning and operating net leased office and industrial...
Harsco’s Rail Division Captures New Rail Grinder Sales in North America
Dec 01, 2016 21:15 pm UTC| Business
CAMP HILL, Pa., Dec. 01, 2016 -- Harsco Corporation’s railway track maintenance division, Harsco Rail, announced today new sales of its railway track grinders for service in contract rail grinding programs throughout...
Haynes International, Inc. announces the development of HAYNES® 233™ alloy
Dec 01, 2016 21:15 pm UTC| Business
KOKOMO, Ind., Dec. 01, 2016 -- Haynes International, Inc. (NASDAQ:HAYN), a leading developer, manufacturer and marketer of technologically advanced high performance alloys, is pleased to announce the development of...
Dec 01, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
DuPont Fabros Technology, Inc. Announces 6% Dividend Increase on Shares of Common Stock
Dec 01, 2016 21:05 pm UTC| Business
WASHINGTON, Dec. 01, 2016 -- DuPont Fabros Technology Inc. (NYSE:DFT), a leading, owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant wholesale data centers, today announced...
Integer Announces Amendment to its Credit Agreement
Dec 01, 2016 21:05 pm UTC| Business
FRISCO, Texas, Dec. 01, 2016 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that it has successfully amended its senior secured credit agreement (the...
Dec 01, 2016 21:05 pm UTC| Business
- Positions Intellia for RD growth and progress toward clinical studies -- Accommodates hiring plans to support pipeline of CRISPR/Cas9 based therapeutics - CAMBRIDGE, Mass., Dec. 01, 2016 -- Intellia Therapeutics,...